We conducted a randomized, double-blind, double-dummy trial comparing two once-daily regimens of edoxaban with warfarin in 21,105 patients with moderate-to-high-risk atrial fibrillation (median follow-up, 2.8 years). The primary efficacy end point was stroke or systemic embolism. Each edoxaban regimen was tested for noninferiority to warfarin during the treatment period. The principal safety end point was major bleeding.
http://www.leadpharmaceutical.com/edoxaban-intermediates-plant/
We conducted a randomized, double-blind, double-dummy trial comparing two once-daily regimens of edoxaban with warfarin in 21,105 patients with moderate-to-high-risk atrial fibrillation (median follow-up, 2.8 years). The primary efficacy end point was stroke or systemic embolism. Each edoxaban regimen was tested for noninferiority to warfarin during the treatment period. The principal safety end point was major bleeding. http://www.leadpharmaceutical.com/edoxaban-intermediates-plant/
China Edoxaban Intermediates Plant Manufacturers, Suppliers, Factory - Edoxaban Intermediates Plant Price - JINAN LEAD
JINAN LEAD is one of the most professional edoxaban intermediates plant manufacturers and suppliers in China. Welcome to buy high quality edoxaban intermediates plant made in China here from our factory. For price consultation, contact us.
WWW.LEADPHARMACEUTICAL.COM
0 Comments 0 Shares
Sponsored

پیج انیمیشن

در این پیج انیمیشن قرا داده می شود